Carvykti Financial Analyst Employer Legend Biotech Location Bridgewater, New Jersey Salary $68045 - $89308 Start date Sep 8, 2026 View more categories View less categories Discipline Administration , Finance Required Education Bachelors Degree Position Type Full time Apply now Save job Click to add the job to your shortlist You need to sign in or create an account to save a job. Send job Job Details Company Job Details Legend Biotech is a global biotechnology company dedicated to treating and, one day, curing life-threatening diseases. Headquartered in Bridgewater, New Jersey, we are advancing the next generation of cell therapy through a portfolio of innovative technologies, including autologous, allogeneic, and in vivo cell therapy approaches. Our research spans chimeric antigen receptor T-cell (CAR-T), T-cell receptor (TCR-T), natural killer (NK) cell-based therapies, and other emerging platforms designed to transform the treatment of serious diseases. From our global network of research and development sites, we are committed to discovering and developing safe, effective, and cutting-edge therapies for patients worldwide. Legend Biotech entered into a global collaboration agreement with Johnson & Johnson to jointly develop and commercialize

CARVYKTI

® (ciltacabtagene autoleucel; cilta-cel). Through this strategic partnership, we combine complementary expertise and capabilities to advance innovative immunotherapies for patients living with multiple myeloma. Legend Biotech is seeking a Carvykti Financial Analyst as part of the Finance team based in Bridgewater, NJ . Role Overview Performing in a fast-paced environment, BCMA Commercial Financial Analyst will be supporting our financial planning and analysis (FP&A) activities. This role will involve close collaboration with Legend's business teams. The ideal candidate possess strong analytical skills with the ability to collect, organize, analyze and disseminate significant amounts of information with attention to detail and accuracy Key Responsibilities Preparation and analysis of complex financial reports, forecasts, and budgets, ensuring accuracy and integrity of financial data. Performing detailed variance analysis and trend identification to assess financial performance and highlight key drivers influencing results. Developing and maintaining sophisticated financial models to support strategic planning, scenario analysis, and investment evaluation. Partnering with business units and senior management to provide financial guidance, recommendations, and support for strategic initiatives. Contributing to the continuous improvement of financial processes, systems, and reporting capabilities to enhance efficiency and effectiveness. Support month-end close activities with the accounting team as requested. Aid in ensuring adherence to key controls and compliance requirements by assisting with documentation and internal audits. Other analytical and reporting tasks as assigned. Requirements Bachelor's Degree required; a major in Accounting or Finance preferred. Mathematical/Analytical progression certification/qualification. 3-5 years of progressive finance or accounting experience. FP&A or a business partnering experience in a matrix environment. Prior life sciences industry experience is preferred. Knowledge of SOX financial controls on Accounting and Reporting processes is preferred. Ability to partner and collaborate with all levels of the organization Advanced proficiency in financial modelling, data analysis, and Microsoft Excel, Powerpoint & PowerBI; experience with financial planning software a plus. Strong quantitative and analytical skills with the ability to synthesize complex financial information into actionable insights. Excellent communication, presentation, and interpersonal skills, with the ability to interact effectively with stakeholders at all levels of the organization Knowledge of common business and financial drivers, financial statement analysis, and deep-dive analysis Experience in continuous improvement initiatives, root cause analysis and project management. High level of accuracy and attention to detail in financial reporting and analysis. Proficient in financial software and tools, including ERP systems and advanced Excel. Experience with S4 Hana and OneStream is a plus. #Li-FB1 #Li-Hybrid The base pay range below is what Legend Biotech USA Inc. reasonably expects to offer at the time of posting. Actual compensation may vary based on experience, skills, qualifications, and geographic location. The company reserves the right to modify this range as needed and in accordance with applicable laws.

Other Types of Pay:

Performance-based bonus and/or equity is available to employees in eligible roles.

Benefits and Paid Time Off:

Medical, dental, and vision insurance as well as a 401(k) retirement plan with a company match that vests fully on day one. We offer eight (8) weeks of paid parental leave after just three (3) months of employment, and a paid time off policy that includes vacation time, personal time, sick time, floating holidays, and eleven (11) company holidays. Additional voluntary benefits include flexible spending and health savings accounts, life and AD&D insurance, short- and long-term disability coverage, legal assistance, and supplemental plans such as pet, critical illness, accident, and hospital indemnity insurance. We also provide voluntary commuter benefits, family planning and care resources, well-being initiatives, and peer-to-peer recognition programs; demonstrating our ongoing commitment to building a culture where our people feel empowered, supported, and inspired to do their best work. Pay Range (Base Pay): $68,045 - $89,308 USD Please note: These benefits are offered exclusively to permanent full-time employees. Contractors are not eligible for benefits through Legend Biotech. Work Authorization & Employment Eligibility Applicants must be authorized to work in the United States. As part of our commitment to maintaining a lawful workforce and ensuring compliance with federal employment regulations, we participate in the E-Verify program. If you are selected for employment, you will be required to complete the Form I-9 process, and your employment eligibility will be verified through E-Verify in accordance with applicable federal law. We are committed to providing a fair, transparent, and welcoming hiring experience for all candidates. EEO Statement It is the policy of Legend Biotech to provide equal employment opportunities without regard to actual or perceived race, color, creed, religion, national origin, ancestry, citizenship status, age, sex or gender (including pregnancy, childbirth, related medical conditions and lactation), gender identity or gender expression (including transgender status), sexual orientation, marital status, military service and veteran status, disability, genetic information, or any other protected characteristic under applicable federal, state or local laws or ordinances. Employment is at-will and may be terminated at any time with or without cause or notice by the employee or the company. For information related to our privacy notice, please review: Legend Biotech Privacy Notice . Company Legend Biotech was founded as an early-stage cell therapy company in 2014. The company was the brainchild of visionary scientists who recognized that antibody-based therapeutics could potentially treat disease and possessed the backgrounds in immunology and gene editing to take the leap. For two years, Legend Biotech, then known as the "Legend Project," operated in a room the size of a freight elevator, with the goal of creating a cell therapy for multiple myeloma, a hematological cancer that often relapses and can become refractory. The team produced nanobodies for single-domain antibody drugs and ultimately extended the half-life of the nanobodies with proprietary technologies. In 2015, Legend's scientists focused on research for chimeric antigen-receptor T-cells (CAR-T) targeting the BCMA protein, making the biotech one of the first companies in the world to engineer CAR-T cells for the BCMA protein. In 2016, investigator-initiated trials began in China. In 2017, data from the trials were presented at the American Society for Clinical Oncology (ASCO), which led to a partnership with biopharmaceutical company Janssen Biotech, Inc. to co-develop the anti-BCMA CAR-T, ciltacabtagene autoleucel (cilta-cel). Applications seeking approval of cilta-cel for the treatment of patients with RRMM are currently under regulatory review by several health authorities around the world.

CARVYKTI

™ (ciltacabtagene autoleucel) was approved by the U.S. Food and Drug Administration in February 2022 and received conditional marketing approval from the European Medicines Agency in May 2022. Today Legend Biotech is a global, commercial-stage company driven by a passion for patients. We continue to build our pipeline of cell therapy platforms, which includes CAR-T, CAR-NK, CAR-γδ T and non-gene-editing CAR technologies. Our goal is to bring hope and opportunity to patients and their families by continuing to explore unique technologies. Company info Location Somerset New Jersey United States Share this job Facebook Twitter LinkedIn Apply now Send job Apply now Save job Click to add the job to your shortlist You need to sign in or create an account to save a job. Get job alerts Create a job alert and receive personalized job recommendations straight to your inbox. Create alert Similar jobs Undergrad Intern Finance (Summer 2027) Washington D.C., District of Columbia Principal Analyst, Commercial Finance Warsaw - Poland MBA Intern Finance & Strategy Leadership Development Program (Summer 2027) Washington D.C., District of Columbia